Currently, vericiguat is approved for use in 35 countries including the United States, European Union countries, the United Kingdom, Japan,…
The Second Edition of the FE Healthcare Summit will be inaugurated by Dr. Mansukh Mandaviya, Union Minister for Health &…
GlobalData forecasts the Chinese medical devices market to grow at a compound annual growth rate of around 6 percent between…
The results suggest that mild to moderate intake of ground, instant and decaffeinated coffee should be considered part of a…
Suresh takes over from S Sridhar, MD Pfizer India Limited, who has been with the association since 2021.
Pfizer India inks partnership with Father Muller Research to award fellowships to younger scientists
Moreover, the bespoke fellowships will be a form of recognition and will enable young clinicians who want to pursue medical…
The company claims that with this launch customers across Nashik and nearby regions can now avail a wide range of…
The Second Edition of FE Healthcare Summit will be inaugurated by Dr. Mansukh Mandaviya, Union Minister for Health & Family…
Furthermore, this move will also help the company in fast-tracking its efforts to take the Truenat platform to global markets,…
According to the researchers, CHAVI has a unified, relational, vast database of de-identified demographic, clinical, pathological, molecular biological, treatment, and…
Interestingly, unlike a standard MRI scan, which can take up to 20 minutes or more, the new 4D heart MRI…
Explaining how the country successfully managed Covid-19, he mentioned that the government had started efforts to understand the virus much…
According to the company, RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal…
Reportedly, Spero’s shares closed down 6.7% at 82 cents on Wednesday, while GSK was marginally down in early trade on…
Fortis Healthcare share price tumbles over 19% during Thursday’s trading session: Fortis’ shares dropped by their most since January 2008,…
Diclofenac topical solution (Pennsaid) is prescribed to relieve osteoarthritis pain in the knees.
In January next year, the Poshan Innovation Platform in January 2023 with the aim to combat undernutrition will be launched…
The company claims that with the launch of its New Delhi centre and other centres across India, Veda is attempting…
